< Terug naar vorige pagina

Octrooi

Oxidative stress and cardiovascular disease events

The present invention relates to diagnosis and/or prognosis of cardiovascular disease and cardiovascular events. A prognostic risk score in relation to the cardiovascular events, more particular after intervention, can be determined by counting the number of deregulated genes (or derived proteins) in their isolated monocytes. Deregulation means low expression of COX1 and/or COX4I1, and/or TFAM, and/or RUNX2.
Octrooi-publicatienummer: US10704097
Bron: USPTO
Jaar aanvraag: 2020
Jaar van publicatie: 2020
Status: Assigned
Technologiedomeinen: Biotechnology
Gevalideerd voor IOF-sleutel: Ja